Medicated Shampoo Market Report 2026

The medicated shampoo market size has grown strongly in recent years. It will grow from $13.84 billion in 2025 to $14.59 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increase in dandruff and scalp disorders, rising urban pollution exposure, growth of pharmacy retail chains, higher awareness of hair and scalp hygiene, availability of otc medicated shampoos.

The medicated shampoo market size is expected to see strong growth in the next few years. It will grow to $17.86 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to rising prevalence of psoriasis and fungal infections, growing demand for personalized scalp care, expansion of online sales channels, increasing focus on preventive hair loss treatment, innovation in active ingredient formulations. Major trends in the forecast period include rising demand for targeted scalp treatment solutions, growing preference for dermatologist-recommended shampoos, increased adoption of herbal and natural medicated formulations, expansion of over-the-counter medicated hair care products, higher consumer awareness of scalp health and hygiene.

The rising prevalence of scalp disorders is expected to drive the growth of the medicated shampoo market in the coming years. Scalp disorders are conditions that affect the skin on the scalp, leading to symptoms such as itching, flaking, inflammation, irritation, or hair loss. Their prevalence is increasing due to factors like environmental pollution, chemical exposure, stress, and lifestyle habits that disrupt the scalp’s natural barrier and microbiome. The medicated shampoo market is responding to this trend by offering formulations containing antifungal, anti-inflammatory, and keratolytic agents that address underlying causes and support scalp healing. For example, in February 2025, the American Academy of Dermatology Association, a US-based non-profit professional organization, reported that acne, one of the most common dermatological conditions, affects 0.05 billion people annually in the United States, underscoring the growing burden of skin and scalp-related disorders that require targeted therapeutic care. Consequently, the increasing prevalence of scalp disorders is fueling the growth of the medicated shampoo market.

Major companies in the medicated shampoo market are prioritizing the development of innovative formulations, such as medicated dry shampoo, to meet increasing consumer demand for convenient, waterless scalp-care solutions that effectively manage dermatological conditions. Medicated dry shampoo is a specialized hair-care product that combines traditional oil-absorbing dry-shampoo properties with therapeutic active ingredients to treat scalp disorders such as dandruff, seborrheic dermatitis, and psoriasis, while allowing application without water. For example, in November 2024, Raven Innovations LLC, a US-based pharmaceutical and personal-care company, introduced RestoraScalp, the world’s first medicated dry shampoo designed to address scalp conditions including dandruff, seborrheic dermatitis, and psoriasis. This innovative product contains 2% salicylic acid as the active therapeutic ingredient, a soothing botanical blend of chamomile, olive leaf, and green tea extracts, and a vegan, cruelty-free, and fragrance-free formulation suitable for all skin types, providing an effective waterless option for scalp treatment on non-wash days.

In February 2025, Cosette Pharmaceuticals Inc., a US-based pharmaceutical company, acquired Mayne Pharma Group Limited for $430 million. Through this acquisition, Cosette Pharmaceuticals aims to strengthen its leadership in women’s health and dermatology by integrating its robust product portfolio with Mayne Pharma’s established commercial and manufacturing capabilities, improving global patient access and fostering innovation in specialty pharmaceuticals. Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company that develops and provides medicated shampoos.

Major companies operating in the medicated shampoo market are Johnson & Johnson, The Procter & Gamble Company, Unilever PLC, Kao Corporation, Cipla Limited, The Himalaya Company, Avalon Natural Products Inc., Ederma Pharma India Private Limited, Elegant Cosmed Private Limited, Luxica Pharma Inc., Yaxon Biocare Pvt. Ltd., Art Naturals Inc., Nioxin Research Laboratories Inc., Sulfur 8 Inc., Summer Laboratories Inc., Mars Medisoap Private Limited, Staple Pharmaceuticals Pvt. Ltd., Astonea Labs Limited, Ketopoz Pharmaceuticals Pvt. Ltd., Maylizz Biotech Private Limited.

North America was the largest region in the medicated shampoo market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medicated shampoo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medicated shampoo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the medicated shampoo market by increasing costs related to imported active pharmaceutical ingredients, specialty chemicals, and packaging materials. The impact is most noticeable in premium and prescription-strength shampoos, particularly in regions dependent on imported formulations such as Asia-Pacific and Latin America. Higher production costs have influenced retail pricing across pharmacy and online channels. However, tariffs have also encouraged local manufacturing, domestic sourcing of ingredients, and formulation optimization, supporting long-term market competitiveness.

The medicated shampoo market research report is one of a series of new reports that provides medicated shampoo market statistics, including medicated shampoo industry global market size, regional shares, competitors with a medicated shampoo market share, detailed medicated shampoo market segments, market trends and opportunities, and any further data you may need to thrive in the medicated shampoo industry. This medicated shampoo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medicated shampoo is a type of shampoo specifically formulated to treat various scalp and hair conditions by delivering medication directly to the scalp. These shampoos contain therapeutic ingredients or drugs that target issues such as dandruff, psoriasis, seborrheic dermatitis, fungal infections, and other scalp-related problems.

The main categories of medicated shampoos address dandruff, baldness, scalp disorders, and hair loss. Dandruff is a scalp condition marked by flaking skin on the scalp, often accompanied by itching. Treatments cover conditions such as dandruff and seborrheic dermatitis, psoriasis, tinea capitis, head lice, and allergic reactions, and are available through supermarkets or hypermarkets, pharmacies and drug stores, department stores, online platforms, and other channels.

The medicated shampoo market consists of sales of anti-dandruff shampoos, anti-itch shampoos, psoriasis shampoos, oily scalp shampoos, and scalp infection shampoos. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.